Mass Spectrometry-Based Solid Phase Peptide Reaction Assay for Detecting Allergenicity Using an Immobilized

Hiroshi Miyazaki1, Yasutaka Samejima2, Kazuya Iwata2

  • 1Medical Device Division, Innovation and Business Development Headquarters, Daicel Corporation, Minato-ku, Tokyo 108-8230, Japan.

Summary

A new mass spectrometry-based assay (M-SPRA) identifies skin sensitizers and peptide adducts. This method overcomes limitations of current assays, offering detailed chemical reactivity analysis for improved toxicology and risk assessment.